1. Home
  2. AMPH vs HEES Comparison

AMPH vs HEES Comparison

Compare AMPH & HEES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • HEES
  • Stock Information
  • Founded
  • AMPH 1996
  • HEES 1961
  • Country
  • AMPH United States
  • HEES United States
  • Employees
  • AMPH N/A
  • HEES N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • HEES Misc Corporate Leasing Services
  • Sector
  • AMPH Health Care
  • HEES Industrials
  • Exchange
  • AMPH Nasdaq
  • HEES Nasdaq
  • Market Cap
  • AMPH 2.5B
  • HEES 2.1B
  • IPO Year
  • AMPH 2014
  • HEES 2006
  • Fundamental
  • Price
  • AMPH $39.54
  • HEES $48.79
  • Analyst Decision
  • AMPH Buy
  • HEES Buy
  • Analyst Count
  • AMPH 4
  • HEES 6
  • Target Price
  • AMPH $60.33
  • HEES $61.25
  • AVG Volume (30 Days)
  • AMPH 607.1K
  • HEES 236.4K
  • Earning Date
  • AMPH 11-06-2024
  • HEES 10-29-2024
  • Dividend Yield
  • AMPH N/A
  • HEES 2.25%
  • EPS Growth
  • AMPH 17.38
  • HEES N/A
  • EPS
  • AMPH 3.01
  • HEES 3.94
  • Revenue
  • AMPH $723,549,000.00
  • HEES $1,518,307,000.00
  • Revenue This Year
  • AMPH $16.86
  • HEES $4.55
  • Revenue Next Year
  • AMPH $10.07
  • HEES $3.91
  • P/E Ratio
  • AMPH $13.01
  • HEES $12.39
  • Revenue Growth
  • AMPH 20.33
  • HEES 5.69
  • 52 Week Low
  • AMPH $36.56
  • HEES $40.92
  • 52 Week High
  • AMPH $65.92
  • HEES $66.18
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 30.89
  • HEES 25.84
  • Support Level
  • AMPH $38.78
  • HEES $48.24
  • Resistance Level
  • AMPH $45.39
  • HEES $56.45
  • Average True Range (ATR)
  • AMPH 1.36
  • HEES 2.05
  • MACD
  • AMPH -0.34
  • HEES -1.29
  • Stochastic Oscillator
  • AMPH 15.69
  • HEES 4.26

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About HEES H&E Equipment Services Inc.

H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.

Share on Social Networks: